tiprankstipranks
Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ:CVKD
US Market

Cadrenal Therapeutics, Inc. (CVKD) Income Statement

Compare
282 Followers

Cadrenal Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Cadrenal Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cadrenal Therapeutics, Inc.'s net income was $-2.41M. See Cadrenal Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ -1.98K$ -1.27K
Operating Expenses
$ 7.63M$ 2.70M
Depreciation and Amortization
$ 1.98K$ 1.27K
EBITDA
$ -8.34M$ -6.61M
Operating Income
$ -7.63M$ -2.70M
Other Income/Expenses
$ -724.24K$ -4.01M
Pretax Income
$ -8.36M$ -6.71M
Net Income
$ -8.36M$ -6.71M
Per Share Metrics
$ ―$ ―
Basic EPS
$ -9.63$ -8.66
Diluted EPS
$ -9.63$ -8.66
Weighted Average Shares Outstanding
868.18K 775.64K
Weighted Average Shares Outstanding (Diluted)
868.18K 775.64K
Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis